Plain-English translation of NCT06472206 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a program called CHAMPS+ that combines two key tools: a smartphone app called WiseApp that reminds you to take your HIV medications and tracks your adherence, plus regular one-on-one support from trained community health workers. The program also uses a smart pill bottle (CleverCap) that dispenses only your prescribed dose and communicates with the app. Together, these tools are designed to help people with HIV consistently take their medications and achieve an undetectable viral load — meaning the virus is controlled and cannot be transmitted to others.
Many people with HIV in the Deep South struggle to take their medications consistently, which prevents them from reaching undetectable viral loads and living their healthiest lives. This trial aims to fill that gap by testing whether combining smartphone technology with direct support from trained community members can make it easier and more sustainable for people to stay on track with their HIV treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly placed into either the standard care group or the CHAMPS+ group. If you're in the CHAMPS+ group, you'll receive a smart pill bottle and the WiseApp smartphone program to help you remember to take your HIV medications. You'll also meet with a community health worker 10 to 12 times over the study period for supportive counseling about sexual health and substance use, especially if your viral load isn't fully controlled. The study lasts about 12 months and involves regular check-ins with the research team and your HIV care providers.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States